FOB Price
Get Latest Price|
- Minimum Order
Country:
Others1
Model No:
CAA-OC-388
FOB Price:
Place of Origin:
-
Price for Minimum Order:
-
Minimum Order Quantity:
-
Packaging Detail:
-
Delivery Time:
-
Supplying Ability:
-
Payment Type:
-
Product Group :
-
Prodcut name | Lidocaine Hydrochloride Powder |
Standard packing material | Aluminum foil bag inside, then waterproof bag or carton |
Appearance | White crystalline powder |
Purity | *9% |
Storage | Preserve in tight,light-resistant containers in a cool place |
1. Lidocaine Hydrochloride Powder
, xylocaine, or lignocaine is a common local
anesthetic and class*1b antiarrhythmic drug. Lidocaine
is used topically to relieve itching, burning,
and pain from skin inflammations, injected as a dental
anesthetic, or as a local anesthetic for minor
surgery.
2.It is on the World Health Organization's List of
Essential Medicines, a list of the most important
medications needed in a basic healthcare
system.
3. Lidocaine is the most important class*1b
antiarrhythmic drug; it is used intravenously for the
treatment of ventricular arrhythmias if amiodarone is not available
or contraindicated.
4. Lidocaine should be given for this indication after
defibrillation, CPR, and vasopressors have been
initiated. A routine prophylactic administration is no
longer recommended for acute cardiac infarction; the
overall benefit of this measure is not
convincing.
Lidocaine Hcl
Description:
1.Lidocaine
Hydrochloride Powder is a local anesthetic and
antiarrhythmic drug. It is clinically used for
infiltration anesthesia, epidural anesthesia,
surface anesthesia (including in the thoracoscopy or
abdominal surgery for mucosal anesthesia) and nerve
conduction block.
2.Lidocaine Hydrochloride Powder is an amide local
anesthetic. With the dose increased, the role
or toxicity increased, there is an anti-convulsive effect
with sub-poisoning plasma concentration; Blood
concentration of more than 5μg • ml*1 can occur
convulsions.
3.Lidocaine Hydrochloride Powder in low doses can
promote outflow of K+ in cardiomyocytes, reduce
myocardial autonomy, and has antiarrhythmic
effects. Increased plasma concentration may cause
slowing of heart conduction, atrioventricular
block, inhibition of myocardial contractility and
decreased cardiac output.
Country: | Others1 |
Model No: | CAA-OC-388 |
FOB Price: | Get Latest Price |
Place of Origin: | - |
Price for Minimum Order: | - |
Minimum Order Quantity: | - |
Packaging Detail: | - |
Delivery Time: | - |
Supplying Ability: | - |
Payment Type: | - |
Product Group : | - |